Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: A 26-week, randomised, treat-to-target trial
Titel:
Insulin degludec/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-/self-mixed insulin: A 26-week, randomised, treat-to-target trial
Auteur:
Kaneko, Shizuka Chow, Francis Choi, Dong Seop Taneda, Shinji Hirao, Koichi Park, Yongsoo Andersen, Thomas Hasseriis Gall, Mari-Anne Christiansen, Jens Sandahl